Clinical Trial Update: A Study of CDX-585 in Patients With Advanced Malignancies [Phase 1]

View source ↗

Summary

Phase 1 trial update showing completed enrollment and results for CDX-585 in patients with advanced solid tumors, including non-small cell lung cancer and gastr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer
• Head and Neck Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Renal Cell Carcinoma

Drugs mentioned

• CDX-585

Snippet

Sponsor: Celldex Therapeutics | Conditions: Non-small Cell Lung Cancer, Gastric Cancer | Phase 1 | Status: COMPLETED